XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses        
Research and development $ 7,658 $ 615 $ 17,553 $ 3,095
General and administrative 2,848 3,731 9,929 6,730
Restructuring expense   1,802   2,292
Total operating expenses 10,506 6,148 27,482 12,117
Loss from operations (10,506) (6,148) (27,482) (12,117)
Other income, net 3 4 7 39
Warrant inducement expense       (4,829)
Loss before income tax benefit (10,503) (6,144) (27,475) (16,907)
Income tax benefit 686   1,775  
Net loss and comprehensive loss $ (9,817) $ (6,144) $ (25,700) $ (16,907)
Net loss per share, basic and diluted $ (0.66) $ (5.51) $ (1.73) $ (16.81)
Weighted-average common shares outstanding, basic and diluted 14,815,852 1,114,133 14,820,822 1,006,008